Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management

MeSH terms

• Action Potentials / drug effects
• Amino Acid Sequence
• Anti-Arrhythmia Agents / adverse effects*
• Anti-Arrhythmia Agents / therapeutic use
• Cation Transport Proteins*
• DNA-Binding Proteins*
• Drug Evaluation, Preclinical
• ERG1 Potassium Channel
• Electrocardiography / drug effects
• Ether-A-Go-Go Potassium Channels
• Genetic Testing
• Genotype
• Humans
• Long QT Syndrome / chemically induced
• Long QT Syndrome / genetics*
• Long QT Syndrome / physiopathology
• Maryland
• Molecular Sequence Data
• Phenotype
• Potassium Channels / drug effects
• Potassium Channels / genetics*
• Potassium Channels, Voltage-Gated*
• Practice Guidelines as Topic
• Torsades de Pointes / chemically induced*
• Trans-Activators*
• Transcriptional Regulator ERG